Close Menu

Randox Laboratories

The test, developed by the firms in six weeks, is part of a viral respiratory panel and runs on Bosch's point-of-care Vivalytic system.

The assay detects 10 STIs and is performed on the molecular point-of-care Vivalytic platform, which was codeveloped by German company Bosch.

The company cites flexibility and ease of use as its main selling points, and is partnering with IVD firms like Randox and R-Biopharm on assay development.

University of Geneva researchers in collaboration with the UK's Proteome Sciences have identified a protein marker that could help doctors better determine the time of stroke onset.

NEW YORK (GenomeWeb News) – Proteome Sciences said today that it has signed a non-exclusive license with Randox Laboratories for use of its stroke protein biomarker portfolio.

Randox Laboratories has launched its Beta-Lactams Array.

Randox Laboratories this week launched its KRAS/BRAF/PIK3CA Array. The company said that clinicians can use the chip to select appropriate patients for colorectal cancer patients undergoing anti-EGFR therapy.

The offering is designed to complement the firm's menu of more focused screening tools.

The funding is for seven projects aimed at creating biomarkers to help guide patients to the most appropriate treatments and at creating drugs and companion diagnostics.

New Product Watch: May 17, 2011

Premium

Fluidigm's 192.24 Dynamic Array IFC, LC Sciences' V17 MicroRNA Microarrays, Arrayjet's Custom Microarray Services, Randox Laboratories' Quantiplasma Array

Pages

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.